Healthcare Industry News: Vertiflex
News Release - October 23, 2007
VertiFlex Appoints Brad Hancock Vice President of SalesSAN CLEMENTE, Calif.--(HSMN NewsFeed)--Vertiflex Inc., a private spinal technology company, today announced it has named Brad Hancock Vice President of Sales. Hancock will manage the U.S. sales and distribution for the company.
Hancock brings 25 years of experience in the medical industry to Vertiflex. For the past 18 years he held senior management positions in Medtronic’s Cardiac Rhythm Device Management, Spinal and Neuromodulation divisions serving as VP of Sales for both Spinal and Neuromodulation for the past 6 years. Hancock led teams that developed a marketplace for emerging technologies for patients suffering from Neurological and Spinal disorders. During his tenure at Medtronic he was part of a task force, along with GE, Abbott, J&J and Baxter, that launched the Global Healthcare Exchange.
“We are very excited to bring Brad into the Vertiflex organization. His prior experience leading sales organizations focused on both competitive industries and underdeveloped markets will provide him the background to support the continued growth of Vertiflex,” said Keegan Harper, Vertiflex’s CEO.
“I am thrilled to be associated with the leaders in emerging technologies within the spinal industry,” said Hancock. “The existing product portfolio and robust pipeline will offer new and unique solutions to our physician and their patients.”
Vertiflex Inc. is headquartered in San Clemente, California. Founded in 2005, the company is a venture-backed medical device company dedicated to the development and advancement of minimally invasive and motion preservation technologies for disorders of the spine. Vertiflex is committed to delivering advanced products that transform patient outcomes focusing on technologies that benefit both the surgeon and patient. For information regarding Vertiflex, please contact Kathryn Larson, Marketing Manager, (949) 940-1400 or info@Vertiflexspine.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.